Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

3articles mentioning institutions

4institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: RWE ×

RWE

This institution is selected. Its supporting articles are shown below.

RWE3

Articles mentioning RWE

3 articles · page 1 of 1

Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the ‘AIRE’ multicentre study

rmdopen · abstract · 2026-03-24 · 2 matching annotations

83.9%

RWE Adalimumab Psoriatic Arthritis Ixekizumab IXE PsA

…trolled trials, but evidence from real-world clinical practice (RWE) remains limited.Methods Adalimumab vs Ixekizumab Real-world Ef…

PO:10:269 Analysis of a monocentric case series of patients with systemic lupus erythematosus treated with belimumab for more than 10 years

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

94.2%

RWE SLE prednisone hydroxychloroquine BEL SLEDAI-2K Lupus

…uous therapy, currently the longest retention rate described in RWE.…

Using real-world data to predict findings of an ongoing phase IV trial: glycemic control of semaglutide versus standard of care

bmjdrc · full text · 2025-10-29 · 1 matching annotations

78.3%

SEPRA trial SEPRA RWE semaglutide type two diabetes mellitus T2DM end-stage renal disease chronic kidney disease type 2 diabetes mellitus diabetic neuropathy+1 more

…vailable. Differences in such factors between our study and the SEPRA trial could affect the results. However, we note that we observed sim…